Literature DB >> 8223648

Expression of human interferon omega 1 in Sf9 cells. No evidence for complex-type N-linked glycosylation or sialylation.

T Voss1, E Ergülen, H Ahorn, V Kubelka, K Sugiyama, I Maurer-Fogy, J Glössl.   

Abstract

Human interferon omega 1 (IFN-omega 1) was expressed in Spodoptera frugiperda Sf9 insect cells using the baculovirus expression system. Half of the protein purified by immunoaffinity chromatography was shown to be N-glycosylated at the same site as the natural IFN-omega 1. The degree of glycosylation was independent of the expression rate. While natural IFN-omega 1 was shown to carry complex-type oligosaccharides [Adolf, G. R., Maurer-Fogy, I., Kalsner, I. & Cantell, K. (1990) J. Biol. Chem. 265, 9290-9295], the insect cell produced protein which was demonstrated by lectin blot, mass spectroscopy and HPLC analysis to contain only the core oligosaccharide. Two different structures, (Man)2(GlcNAc)2[Fuc] and (Man)3(GlcNAc)2[Fuc] were identified. The fucosylation was identified to be (alpha 1-6)-linked to the core saccharide. Sialic acid residues were clearly absent. IFN-omega 1 expressed in S. frugiperda cells was shown to be partially truncated at the C-terminus by nine residues; its antiviral activity when glycosylated was significantly lower than the activity of IFN-omega 1 produced by Sendai-virus-stimulated leukocytes. Circular dichroism and fluorescence spectroscopy did not reveal any structural differences between glycosylated and nonglycosylated IFN-omega 1. This implies the importance of a complex-type glycosylation for the maximal biological activity of human IFN-omega 1.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8223648     DOI: 10.1111/j.1432-1033.1993.tb18321.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  11 in total

1.  Structured modelling of animal cells.

Authors:  C S Sanderson; P J Phillips; J P Barford
Journal:  Cytotechnology       Date:  1996-06       Impact factor: 2.058

Review 2.  More than silk and honey--or, can insect cells serve in the production of therapeutic glycoproteins?

Authors:  F Altmann
Journal:  Glycoconj J       Date:  1997-08       Impact factor: 2.916

Review 3.  Glycoproteins from insect cells: sialylated or not?

Authors:  I Marchal; D L Jarvis; R Cacan; A Verbert
Journal:  Biol Chem       Date:  2001-02       Impact factor: 3.915

Review 4.  Insect cells as hosts for the expression of recombinant glycoproteins.

Authors:  F Altmann; E Staudacher; I B Wilson; L März
Journal:  Glycoconj J       Date:  1999-02       Impact factor: 2.916

5.  Posttranslational processing of recombinant human interferon-gamma in animal expression systems.

Authors:  D C James; M H Goldman; M Hoare; N Jenkins; R W Oliver; B N Green; R B Freedman
Journal:  Protein Sci       Date:  1996-02       Impact factor: 6.725

6.  Structural characterization of the N-linked oligosaccharides derived from HIVgp120 expressed in lepidopteran cells.

Authors:  T D Butters; B Yudkin; G S Jacob; I M Jones
Journal:  Glycoconj J       Date:  1998-01       Impact factor: 2.916

7.  Expression and characterization of recombinant human alpha-3/4-fucosyltransferase III from Spodoptera frugiperda (Sf9) and Trichoplusia ni (Tn) cells using the baculovirus expression system.

Authors:  V A Morais; J Serpa; A S Palma; T Costa; L Maranga; J Costa
Journal:  Biochem J       Date:  2001-02-01       Impact factor: 3.857

Review 8.  Comparing N-glycan processing in mammalian cell lines to native and engineered lepidopteran insect cell lines.

Authors:  Noboru Tomiya; Someet Narang; Yuan C Lee; Michael J Betenbaugh
Journal:  Glycoconj J       Date:  2004       Impact factor: 2.916

9.  Human alpha-galactosidase A: glycosylation site 3 is essential for enzyme solubility.

Authors:  Y A Ioannou; K M Zeidner; M E Grace; R J Desnick
Journal:  Biochem J       Date:  1998-06-15       Impact factor: 3.857

10.  The α1,6-fucosyltransferase gene (fut8) from the Sf9 lepidopteran insect cell line: insights into fut8 evolution.

Authors:  Sylvie Juliant; Anne Harduin-Lepers; François Monjaret; Béatrice Catieau; Marie-Luce Violet; Pierre Cérutti; Annick Ozil; Martine Duonor-Cérutti
Journal:  PLoS One       Date:  2014-10-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.